PPA
CYCN icon

Parametric Portfolio Associates’s Cyclerion Therapeutics CYCN Stock Holding History

Parametric Portfolio Associates’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-630
Closed -$49K – 3617
2021
Q2 		$49K Sell
630
-683
-52% -$42.8K ﹤0.01% 3536
2021
Q1 		$73K Buy
1,313
+196
+18% +$14.7K ﹤0.01% 3998
2020
Q4 		$68K Buy
1,117
+216
+24% +$14.7K ﹤0.01% 3919
2020
Q3 		$110K Buy
901
+94
+12% +$10.7K ﹤0.01% 3777
2020
Q2 		$95K Sell
807
-1,169
-59% -$97.7K ﹤0.01% 3797
2020
Q1 		$105K Buy
1,976
+846
+75% +$60.4K ﹤0.01% 3723
2019
Q4 		$61K Buy
+1,130
New +$106K ﹤0.01% 3910

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return